Victory Capital Management Inc. Sells 17,898 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Victory Capital Management Inc. cut its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 48.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,942 shares of the company’s stock after selling 17,898 shares during the period. Victory Capital Management Inc.’s holdings in Henry Schein were worth $1,381,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of HSIC. Cromwell Holdings LLC increased its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC acquired a new position in Henry Schein in the second quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the second quarter worth about $37,000. Blue Trust Inc. boosted its holdings in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently commented on HSIC. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. UBS Group cut their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Henry Schein Trading Up 2.3 %

Shares of NASDAQ:HSIC opened at $76.84 on Tuesday. The company has a market capitalization of $9.58 billion, a P/E ratio of 31.62, a P/E/G ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s 50 day simple moving average is $70.89 and its 200 day simple moving average is $69.73.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business posted $1.32 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. On average, research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.